Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Primitif du foie
- | Specialty :
- Thérapies Ciblées
Extract
A randomized, double-blind, multi-center phase III study of brivanib plus best supportive care (BSC) versus placebo plus BSC in subjects with advanced hepatocellular carcinoma (HCC) who have failed or are intolerant to sorafénib.
Scientific Abstract
en cours d'intégration;